DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast CancerNota de prensa9 abril, 2026 · 14:16 | PR News
J.S. Held Strengthens Cross-Disciplinary Response to Artificial Intelligence (AI) DisputesNota de prensa9 abril, 2026 · 14:07 | PR News
Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)Nota de prensa9 abril, 2026 · 14:03 | PR News
MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMSNota de prensa9 abril, 2026 · 14:03 | PR News
Nancy L. Lewis, MD, MBS, FACP, nombrada directora científica de National Comprehensive Cancer NetworkNota de prensa9 abril, 2026 · 14:03 | PR News
Para celebrar el hito de 100.000 pacientes tratados, Nordic Pharma Inc. (EE.UU.) amplía su ofertaNota de prensa9 abril, 2026 · 14:03 | PR News